Who invested in Bioantibody?
Bioantibody's investors include Bond, Industry Ventures and Shine Capital.
Who invested in Bioantibody
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $15MJan 2023
- Investors
- 3
The rounds
- Jan 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Bioantibody
How much has Bioantibody raised?
Bioantibody has raised $15M across 1 round since 2023.
When did Bioantibody last raise?
Bioantibody's most recent round was a Series A of $15M in Jan 2023.
What was Bioantibody's biggest round?
Its most recent round, $15M in Jan 2023, is also its largest on record.
Who backed Bioantibody first?
Bioantibody's first round on record, in Jan 2023, was backed by Bond, Industry Ventures and Shine Capital.
What stage is Bioantibody at?
Bioantibody's latest named round is a Series A, in Jan 2023.
Companies like Bioantibody
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.